The U.S. Supreme Court on Monday asked the solicitor general to weigh in on Teva Pharmaceutical USA Inc.’s challenge to a California appeals court finding that the generic-drug maker can be held liable for injuries because it did not immediately update its warning label to match the brand-name equivalent version. In June 2013 the California appeals panel gave the go …